Quantum Valley Investments

Quantum Valley Investments is a venture capital firm focused on early-stage investments in quantum information science and related technologies, including quantum computing, with an emphasis on commercialization of quantum innovations. It is headquartered in Waterloo, Ontario, Canada, and was founded in 2013 by BlackBerry co-founders Mike Lazaridis and Doug Fregin. The firm backs startups developing quantum technologies and information technology and cybersecurity solutions, aiming to translate laboratory breakthroughs into market-ready products and to strengthen the Waterloo region’s technology ecosystem.

Mike Lazaridis

Founder / Managing Partner

2 past transactions

Virsec

Series C in 2021
Virsec is a cybersecurity company based in San Jose, California, that specializes in protecting software from cyber threats through innovative self-protection technology. By securing server workloads at runtime, Virsec's software continuously safeguards critical applications from both known and unknown attacks, including zero-day vulnerabilities. The company's patented approach involves mapping acceptable application behavior and instantly identifying any deviations caused by malicious activity, thereby enabling real-time detection and response to cyber threats. Virsec's solutions have been rigorously tested against elite cybersecurity teams and are trusted by numerous Fortune 100 companies, demonstrating the effectiveness of its protection-first model in enhancing application security.

ISARA Corporation

Seed Round in 2015
ISARA Corporation specializes in quantum-resistant security solutions. Founded in 2015, it offers ISARA Radiate for secure network migration and ISARA Catalyst for digital certificate technology. Its mission is to enable a quantum-safe world by collaborating with academic institutions to design global quantum-safe solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.